Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-01-31

FDA Approved: LEVETIRACETAM — Original Application (Hp Halden Pharma AS)

View source ↗

Summary

FDA approved the original application for Levetiracetam (Hp Halden Pharma AS), a generic formulation used to treat epilepsy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LEVETIRACETAM (levetiracetam)

Snippet

ORIG AP for LEVETIRACETAM (LEVETIRACETAM)